Be productive and inspired whilst maintaining a safe physical distance

Truth Parade | COVID-19 News | Charlotte-Based | Latest Pandemic News and stories

The Updated Ones Established Truth-Parade To Provide North Carolina, Charlotte Area Residents, and Locales Around The World, Fact-Based COVID-19 Resources, Nonpartisan Science News, and Science-Backed Data associated with the pandemic.


COVID-19 Vaccine Dose Interval, WHO Experts Weigh In
Coronavirus (COVID-19) | CIDPRAP | COVID-19 Vaccines | World News

COVID-19 Vaccine Dose Interval, WHO Experts Weigh In

The WHO says it was disappointed with China over visa problems for the international joint mission and that the B117 variant has been found in 40 nations. Source: Center for Infectious Disease Research and Policy…

CIDPRAP | Coronavirus (COVID-19)

Less than 10% of Americans had COVID by September, study finds

Chris Dall | News Reporter | CIDRAP NewsNov 25, 2020Through Sep 24, the CDC says, seroprevalence rates ranged from 0% to 23%. CIDRAP…

WHO Pushes for COVID Vaccine Production Scale-Up, More Sharing
Centers for Disease Control and Prevention | CIDPRAP | Coronavirus (COVID-19) | COVID-19 | COVID-19 Spread | COVID-19 vaccine distribution plan | COVID-19 Vaccines | Face Masks and Coverings | Global Science News | Hospitals | Pandemic | Variant COVID-19 Strain

WHO Pushes for COVID Vaccine Production Scale-Up, More Sharing

Lisa Schnirring | News Editor | CIDRAP NewsFeb 05, 2021The global number of people vaccinated has now eclipsed the number infected. Source: Center for Infectious Disease Research and Policy…

Centers for Disease Control and Prevention | CIDPRAP | Coronavirus (COVID-19) | Coronavirus [CoV] | Face Masks and Coverings | Global Science News | Immune System

To Extract More Doses per Vial, Vaccinators Put Squeeze on FDA to Relax Vaccine Handling Advice

Arthur Allen March 12, 2021 President Joe Biden has promised enough covid vaccine to immunize every willing adult by June 1. But right now, the gap between supply and demand is

California Counties a Hodgepodge of Highs and Lows in Vaccinating Vulnerable Seniors
Aging | California | Centers for Disease Control and Prevention | Clinics | Community Health | Coronavirus (COVID-19) | Coronavirus Disease 2019 | COVID-19 | COVID-19 Spread | COVID-19 vaccine distribution plan | COVID-19 Vaccines | Public Health | States | Vaccines

California Counties a Hodgepodge of Highs and Lows in Vaccinating Vulnerable Seniors

Like many states, California is seeing huge regional variations in covid vaccination rates for people 65 and older. Remote rural counties are in some cases struggling to give away doses to vulnerable seniors, while metropolitan areas often have more demand than supply. …

CIDPRAP | Coronavirus (COVID-19)

CIDRAP News Headlines for Dec 23, 2020

COVID-19 hospital outcomesLeafy greens E coli probe endsAvian flu in Europe, Japan Source: Center for Infectious Disease Research and Policy…

CDC  Vaccination Frequently Asked Questions
Vaccines | COVID-19 Vaccines

CDC Vaccination Frequently Asked Questions

CDC Vaccination Frequently Asked Questions | Find answers to commonly asked questions about COVID-19 vaccination. CDC also has information for busting common vaccine myths available on facts about COVID-19 vaccines.

Three Studies Highlight Low COVID Risk of In-Person School
Coronavirus (COVID-19) | CIDPRAP | COVID-19 | COVID-19 Spread | COVID-19 Vaccines | Face Masks and Coverings | Immune System | National News | Pandemic

Three Studies Highlight Low COVID Risk of In-Person School

Mary Van Beusekom | News Writer | CIDRAP News | Jan 08, 2021 | Studies spotlight limited in-school COVID-19 spread in North Carolina, Sweden, and Norway. Source: Center for Infectious Disease Research and Policy…

South Carolina Detects South African COVID-19 Variant
Variant COVID-19 Strain | Centers for Disease Control and Prevention | CIDPRAP | Coronavirus (COVID-19) | COVID-19 | COVID-19 Spread | COVID-19 vaccine distribution plan | COVID-19 Vaccines | Face Masks and Coverings | Global Science News | Hospitals | Pandemic

South Carolina Detects South African COVID-19 Variant

South Carolina Detects South African COVID-19 Variant Also, an expert warns about hospital oxygen shortages and Novavax reports good phase 3 vaccine data.

Immune System | Coronavirus (COVID-19)

Research Deep Underway: Immune Response to COVID Virus Answers Can Lead to Better Treatment and Vaccines, Scientists Say

The John Hopkins University School of Medicine along with Johns Hopkins Bloomberg School of Public Health have recently announced a new program central t

California’s Top Hospital Lobbyist Cements Influence in Covid Crisis
Coronavirus (COVID-19) | California | COVID-19 | Hospitals | Nurses | States

California’s Top Hospital Lobbyist Cements Influence in Covid Crisis

California’s Top Hospital Lobbyist Cements Influence in Covid Crisis | SACRAMENTO — As intensive care units filled and coronavirus cases surged over the holidays, Carmela Coyle invoked a World War II-era quote attributed to British Prime Minister Winston Churchill to rally her own troops: “If you’re going through hell, keep going.”

Centers for Disease Control and Prevention | Coronavirus (COVID-19)

CDC Awards $3 Billion to Expand COVID-19 Vaccine Programs

The Centers for Disease Control and Prevention (CDC) has awarded funding to support local efforts to increase vaccine uptake by expanding COVID-19 vaccine programs and ensuring greater equity and access to vaccine by those disproportionately affected by SARS-CoV-2, the virus that…

4 Things to Know About the J&J Covid Vaccine Pause
COVID-19 Vaccines | Biden Vaccine Rollout | Centers for Disease Control and Prevention | Coronavirus (COVID-19) | COVID-19 | COVID-19 Spread | Vaccines

4 Things to Know About the J&J Covid Vaccine Pause

Four months into the largest U.S. vaccine rollout in decades, it’s become clear that the messaging surrounding covid-19 vaccination efforts is as important as the science behind them. That was true when the first covid vaccines were introduced in December at hospitals and nursing homes and even more so after the federal government on Tuesday paused the Johnson and Johnson vaccine after reports of extremely rare but very serious — in one case, fatal — side effects emerged.

CDC: Variant COVID-19 Strain Likely Circulating In Many States
Coronavirus (COVID-19) | CIDPRAP | COVID-19 Spread | Global Science News | Variant COVID-19 Strain

CDC: Variant COVID-19 Strain Likely Circulating In Many States

Stephanie Soucheray | News Reporter | CIDRAP News Jan 07, 2021 | There are now at least 56 cases of the variant B117 in 8 states; California and Florida have the most. Source: Center for Infectious Disease Research and Policy…

Coronavirus News Roundup, February 6 – February 12
Coronavirus (COVID-19) | CIDPRAP | COVID-19 | COVID-19 Spread | COVID-19 vaccine distribution plan | COVID-19 Vaccines | Health | Immune System | Pandemic | Public Health | Vaccines | Variant COVID-19 Strain

Coronavirus News Roundup, February 6 – February 12

Pandemic highlights for the week from ScientificAmerican.com

How Will the Coronavirus Evolve?
CIDPRAP | Coronavirus (COVID-19) | COVID-19 | COVID-19 Spread | COVID-19 vaccine distribution plan | Health | Pandemic | Public Health | Variant COVID-19 Strain

How Will the Coronavirus Evolve?

With declining rates of new infections and the rollout of vaccines, some are beginning to speak of an end to COVID-19. But that rhetoric, in my opinion, is ill-considered and premature. Based on what we know now of SARS-CoV-2, it may no longer be a question of months before an end to the pandemic but a question of years, if not decades. We should plan for it.

US child COVID hospital rates vary widely by state, time

Mary Van Beusekom | News Writer | CIDRAP News | Jan 12, 2021The cumulative pediatric hospitalization rate jumped from 2.0 per 100,000 children in May to 7.2 in November. Source: Center for Infectious Disease Research and Policy…

U.S. Sees Record COVID-19 Deaths in December

Chris Dall | News Reporter | CIDRAP NewsDec 28, 2020 The next few months could be difficult, if Christmas and New Years gatherings and travel seed a new surge in infections. Source: Center for Infectious Disease Research and Policy…


4 Things to Know About the J&J Covid Vaccine Pause

Four months into the largest U.S. vaccine rollout in decades, it’s become clear that the messaging surrounding covid-19 vaccination efforts is as important as the science behind them. That was true when the first covid vaccines were introduced in December at hospitals and nursing homes and even more so after the federal government on Tuesday paused the Johnson and Johnson vaccine after reports of extremely rare but very serious — in one case, fatal — side effects emerged.

Continue Reading 4 Things to Know About the J&J Covid Vaccine Pause

Daily Confirmed COVID-19 Cases per million

Max Roser, Hannah Ritchie, Esteban Ortiz-Ospina and Joe Hasell (2020) - "Coronavirus Pandemic (COVID-19)". Published online at OurWorldInData.org. Retrieved from: 'https://ourworldindata.org/coronavirus' [Online Resource]
Chart(s) may not appear correctly on mobile devices. We're currently working to fix this. Sorry for this inconvenience. 

COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University

This is the data repository for the 2019 Novel Coronavirus Visual Dashboard operated by the Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE). Also, Supported by ESRI Living Atlas Team and the Johns Hopkins University Applied Physics Lab (JHU APL). https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30120-1/

Truth Parade | COVID-19

Charlotte-Based Pandemic News

COVID-19 Vaccine Information – Truth | Fact | Science

covid-19 Image
Image Source: CDC.GOV

Benefits of Getting a COVID-19 Vaccine

We understand that some people may be concerned about getting vaccinated now that COVID-19 vaccines are available in the United States. While more COVID-19 vaccines are being developed as quickly as possible, routine processes and procedures remain in place to ensure the safety of any vaccine that is authorized or approved for use. Safety is a top priority, and there are many reasons to get vaccinated.

Can a COVID-19 vaccine make me sick with COVID-19?

No. None of the COVID-19 vaccines contain the live virus that causes COVID-19 so a COVID-19 vaccine cannot make you sick with COVID-19. Facts about COVID-19 Vaccines

Below is a summary of the benefits of COVID-19 vaccination based on what we currently know. CDC will continue to update this page as more data become available.

COVID-19 vaccination will help keep you from getting COVID-19

  • All COVID-19 vaccines currently available in the United States have been shown to be highly effective at preventing COVID-19. Learn more about the different COVID-19 vaccines.
  • All COVID-19 vaccines that are in development are being carefully evaluated in clinical trials and will be authorized or approved only if they make it substantially less likely you’ll get COVID-19. Learn more about how federal partners are ensuring COVID-19 vaccines work.
  • Based on what we know about vaccines for other diseases and early data from clinical trials, experts believe that getting a COVID-19 vaccine may also help keep you from getting seriously ill even if you do get COVID-19.
  • Getting vaccinated yourself may also protect people around you, particularly people at increased risk for severe illness from COVID-19.
  • Experts continue to conduct more studies about the effect of COVID-19 vaccination on severity of illness from COVID-19, as well as its ability to keep people from spreading the virus that causes COVID-19.

COVID-19 vaccination is a safer way to help build protection

  • COVID-19 can have serious, life-threatening complications, and there is no way to know how COVID-19 will affect you. And if you get sick, you could spread the disease to friends, family, and others around you.
  • Clinical trials of all vaccines must first show they are safe and effective before any vaccine can be authorized or approved for use, including COVID-19 vaccines. The known and potential benefits of a COVID-19 vaccine must outweigh the known and potential risks of the vaccine for use under what is known as an Emergency Use Authorization (EUA). Watch a video on what an EUA is.
  • Getting COVID-19 may offer some natural protection, known as immunity. Current evidence suggests that reinfection with the virus that causes COVID-19 is uncommon in the 90 days after initial infection. However, experts don’t know for sure how long this protection lasts, and the risk of severe illness and death from COVID-19 far outweighs any benefits of natural immunity. COVID-19 vaccination will help protect you by creating an antibody (immune system) response without having to experience sickness.
  • Both natural immunity and immunity produced by a vaccine are important parts of COVID-19 disease that experts are trying to learn more about, and CDC will keep the public informed as new evidence becomes available.

COVID-19 vaccination will be an important tool to help stop the pandemic

  • Wearing masks and social distancing help reduce your chance of being exposed to the virus or spreading it to others, but these measures are not enough. Vaccines will work with your immune system so it will be ready to fight the virus if you are exposed.
  • The combination of getting vaccinated and following CDC’s recommendations to protect yourself and others will offer the best protection from COVID-19.
  • Stopping a pandemic requires using all the tools we have available. As experts learn more about how COVID-19 vaccination may help reduce spread of the disease in communities, CDC will continue to update the recommendations to protect communities using the latest science.

Related Pages

Frequently Asked Questions about COVID-19 Vaccination

Ensuring the Safety of COVID-19 Vaccines in the United States

Content provided and maintained by the US Centers for Disease Control and Prevention (CDC). Please see our system usage guidelines and disclaimer.

CDC’s COVID-19 Vaccine Rollout Recommendations

Because the U.S. supply of COVID-19 vaccine is expected to be limited at first, CDC is providing recommendations to federal, state, and local governments about who should be vaccinated first. CDC’s recommendations are based on those from the Advisory Committee on Immunization Practices (ACIP), an independent panel of medical and public health experts.

The recommendations were made with these goals in mind:

  • Decrease death and serious disease as much as possible.
  • Preserve functioning of society.
  • Reduce the extra burden COVID-19 is having on people already facing disparities.

While CDC makes recommendations for who should be offered COVID-19 vaccine first, each state has its own plan for deciding who will be vaccinated first and how they can receive vaccines. Please contact your local health department for more information on COVID-19 vaccination in your area.

Healthcare personnel and residents of long-term care facilities should be offered the first doses of COVID-19 vaccines (1a)

CDC recommends that initial supplies of COVID-19 vaccine be allocated to healthcare personnel and long-term care facility residents. This is referred to as Phase 1a. Phases may overlap. CDC made this recommendation on December 3, 2020.

Healthcare Personnel

Learn more about why it’s important that healthcare personnel get vaccinated and who is included.Healthcare Personnel

Long-term Care Facility Residents

Learn more about why it’s important that residents of long-term care facilities get vaccinated and who is included.​Long-term Care Facility Residents

Groups who should be offered vaccination next (1b and 1c)

CDC recommends that in Phase 1b and Phase 1c, which may overlap, vaccination should be offered to people in the following groups. CDC made this recommendation on December 22, 2020.

Phase 1b

  • Frontline essential workers such as fire fighters, police officers, corrections officers, food and agricultural workers, United States Postal Service workers, manufacturing workers, grocery store workers, public transit workers, and those who work in the educational sector (teachers, support staff, and daycare workers.)
  • People aged 75 years and older because they are at high risk of hospitalization, illness, and death from COVID-19. People aged 75 years and older who are also residents of long-term care facilities should be offered vaccination in Phase 1a.

Phase 1c

  • People aged 65—74 years because they are at high risk of hospitalization, illness, and death from COVID-19. People aged 65—74 years who are also residents of long-term care facilities should be offered vaccination in Phase 1a.
  • People aged 16—64 years with underlying medical conditions which increase the risk of serious, life-threatening complications from COVID-19.
  • Other essential workers, such as people who work in transportation and logistics, food service, housing construction and finance, information technology, communications, energy, law, media, public safety, and public health.

As vaccine availability increases, vaccination recommendations will expand to include more groups

The goal is for everyone to be able to easily get a COVID-19 vaccination as soon as large enough quantities of vaccine are available. As vaccine supply increases but remains limited, ACIP will expand the groups recommended for vaccination.More Information

  • Vaccine Considerations for People who are Pregnant or Breastfeeding
  • How CDC Is Making COVID-19 Vaccine Recommendations
  • Role of the Advisory Committee on Immunization Practices in CDC’s Vaccine Recommendations

Content provided and maintained by the US Centers for Disease Control and Prevention (CDC). Please see our system usage guidelines and disclaimer.

Photo Source: CDC.gov
Source: CDC Website